alexa Interview | Giovanni TosinbspPharmaceutica Analytica Ac
ISSN : 2153-2435

Pharmaceutica Analytica Acta
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 
 
Giovanni Tosi
Giovanni Tosi

Giovanni Tosi
Pharmaceutical Technology
University of Modena and Reggio Emilia
Italy
Read Interview session with Giovanni Tosi

 
Biography

Dr. Giovanni Tosi was born on 1977. Since 15th November 2005, is researcher in the scientific field of Pharmaceutical Technology at the University of Modena and Reggio Emilia. Actually is confirmed researcher, at the department of Pharmaceutical Sciences and belongs to the faculty of Pharmacy.

 
Research Interest

The research activity is based on the development of lipid and polymeric systems for the delivery and the targeting of drugs to diseased tissues or cells. In particular, the fields of research could be summarized as follows:
Drug delivery to the Central Nervous System, by using nanoparticulate vectors  in particular, the research is focus on the planning, preparation, characterization and administration of Np after surface modifications. By applying in vivo pharmacological tests, personally performed by dr. Tosi, several interesting results have been reached, confirming the high potential of these systems. In particular, the Np, loaded with selected drugs or labeled with fluorescent dyes, were found to be able to cross the Blood-brain barrier, opening the study to the possibility of a non-invasive treatment of cerebral pathologies. At the same time, considering the guidelines of the European Community and FDA, a number of studies on the biodistribution of these vectors, by using fluorescent dye and HPLC/fluorimetric methodologies.

Interview

1. How many years have you been practicing and/or performing research?
I was involved in research since 2000, it is almost 15 years of driving research.

2. What is the research topic you are working on now?
My topics are mainly based on nanomedicine for innovative treatment in Central Nervous System and tumor. Nanotechnology applied to medicine.

3. What makes an article top quality?
Top quality articles are constituted by different skilled researcher in many fields, with competences in complementary topics, all sharing the same objective.

4. What are the qualities you look for in an article?
a. Interdisciplinarity
b. Methods and protocol reproducibile
c. Clear results and clear discussion
d. Absence of not proven hypothesis.

5. Do you have any research funding (NIH or other national funding) now?
Yes, Grant from Neurodegenerative associations and Italian Grants.

6. When did you become an editor of OMICS Journal?
2012.

7. What is your greatest career accomplishment?
Hot topic issue in Society for Neurosciene world meeting for 2012 and 2013.

8. How does the research published percolate through to practitioners?
This is the most important topic: how to translate research findings to application. This is only possible by producing results, reproducible and innovative, with great level of interdisciplinarity and with good perspective to Industrial field for scale up processes.

9. What is the purpose of serving as an editor?
To select only high papers.

10. Do you have any patents?
Yes, a couple.

11. Have you contributed any editorials or papers (any types) to OMICS Journals in the past two years?
Unfortunately no.

12. Do you plan to contribute any editorials or papers to OMICS Journals in the next year?
Yes.

13. Do you have any trouble with OMICS Journals in the past?
No.

14. Would you recommend OMICS to your friends or colleagues?
Yes.

15. How do you differentiate Pharmaceutica Analytica Acta with other journals in the field?
To organize sections for specific pathology and innovation in treatments, at the cutting edge of technology.

 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords